Published in BMC Infect Dis on January 07, 2014
The global burden of liver disease: a challenge for methods and for public health. BMC Med (2014) 1.01
Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol (2014) 0.94
Hepatitis B virus burden in developing countries. World J Gastroenterol (2015) 0.91
A preventable cancer. Nature (2014) 0.86
Cancer prevention as part of precision medicine: 'plenty to be done'. Carcinogenesis (2015) 0.86
Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Hepat Mon (2016) 0.84
Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep (2016) 0.79
Barriers to timely administration of birth dose vaccines in The Gambia, West Africa. Vaccine (2016) 0.78
Prevention of hepatitis B. Cold Spring Harb Perspect Med (2015) 0.76
Population-based interventions to reduce the public health burden related with hepatitis B virus infection in the gambia, west Africa. Trop Med Health (2014) 0.75
Health care workers in Pearl River Delta Area of China are not vaccinated adequately against hepatitis B: a retrospective cohort study. BMC Infect Dis (2015) 0.75
Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination. Ghana Med J (2017) 0.75
Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population. PLoS One (2017) 0.75
Hepatitis B virus infection. Lancet (2009) 5.78
Part I: Cancer in Indigenous Africans--burden, distribution, and trends. Lancet Oncol (2008) 3.91
Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis (2002) 3.19
The global impact of vaccination against hepatitis B: a historical overview. Vaccine (2008) 2.84
The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group. Cancer Res (1987) 2.18
The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12
Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res (2000) 2.09
What level of hepatitis B antibody is protective? J Infect Dis (1999) 2.02
Hepatitis B vaccination: protection for how long and against what? BMJ (1993) 1.90
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer (2011) 1.54
Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ (2002) 1.52
Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet (1991) 1.46
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis (2006) 1.38
Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine (2009) 1.34
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis (1990) 1.31
The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis (2011) 1.24
Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet (1993) 1.15
The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis (1992) 1.13
The natural history of chronic hepatitis B. J Viral Hepat (2007) 1.06
Seroprevalence of markers for hepatitis B viral infection. Int J Infect Dis (2010) 1.06
Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life. Vaccine (2006) 0.92
Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. The Gambia Hepatitis Study Group. Lancet (1989) 0.88
Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors. Br J Biomed Sci (2005) 0.82
Loss of antibodies, but not of protection. Lancet Infect Dis (2010) 0.82
Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet (2008) 9.05
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med (2004) 7.62
What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis (2004) 4.87
The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med (2011) 3.25
Measles eradication: past is prologue. Lancet (2010) 3.00
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet (2006) 2.94
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis (2003) 2.75
Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol (2008) 2.59
Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet (2002) 2.34
Validation of the diagnosis of autism in general practitioner records. BMC Public Health (2004) 2.22
Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr (2004) 2.14
Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis. AIDS (2014) 2.07
Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol (2006) 2.05
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ (2004) 2.03
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol (2008) 2.03
MMR vaccination and pervasive developmental disorders: a case-control study. Lancet (2004) 2.02
Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis Rheum (2007) 1.98
Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ Health Perspect (2004) 1.97
Intra-rater and inter-rater reliability of a weight-bearing lunge measure of ankle dorsiflexion. Aust J Physiother (1998) 1.96
A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis (2004) 1.77
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine (2003) 1.65
An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting. Int J Epidemiol (2005) 1.58
Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ Health Perspect (2003) 1.53
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr (2013) 1.51
Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. AIDS (2003) 1.46
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ (2010) 1.46
Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J Immunol (2010) 1.45
Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ (2004) 1.45
Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology (2006) 1.45
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res (2006) 1.44
A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. Am J Hum Genet (2005) 1.43
Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A (2006) 1.41
Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS (2002) 1.41
Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood (2006) 1.39
JCVI processes are at least as robust as those of scientific journals. BMJ (2012) 1.38
The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS (2011) 1.38
Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J Immunol (2006) 1.36
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One (2007) 1.33
Liver cancer in low and middle income countries. BMJ (2003) 1.33
The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa. J Gastroenterol Hepatol (2002) 1.32
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet (2007) 1.32
Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS (2004) 1.26
Reaching millennium development goal 4 - the Gambia. Trop Med Int Health (2011) 1.25
Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol (2007) 1.25
Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol (2009) 1.23
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? Nat Immunol (2007) 1.17
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One (2008) 1.16
Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet (2006) 1.13
Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial. PLoS One (2012) 1.13
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev (2005) 1.12
Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol (2011) 1.12
A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS (2008) 1.11
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One (2013) 1.10
A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia. Malar J (2011) 1.09
Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine (2010) 1.09
Implications of familial colorectal cancer risk profiles and microsatellite instability status. J Clin Oncol (2009) 1.08
Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infect Dis (2013) 1.08
Stigmatising attitudes among people offered home-based HIV testing and counselling in Blantyre, Malawi: construction and analysis of a stigma scale. PLoS One (2011) 1.08
The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine (2012) 1.08
Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia. J Acquir Immune Defic Syndr (2005) 1.07
EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia. Trop Med Int Health (2004) 1.04
Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia (2005) 1.03
Case-control study of mosquito nets against malaria in the Amazon region of Colombia. Am J Trop Med Hyg (2005) 1.03
Evaluation of data quality at the Gambia national cancer registry. Int J Cancer (2012) 1.02
Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage? Trop Med Int Health (2005) 1.02
Development and validation of a global positioning system-based "map book" system for categorizing cluster residency status of community members living in high-density urban slums in Blantyre, Malawi. Am J Epidemiol (2013) 1.02
Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, Uganda. Public Health Nutr (2013) 1.01
Racial and geographic factors in the incidence of Legg-Calvé-Perthes' disease: a systematic review. Am J Epidemiol (2012) 1.01
Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression. J Gastroenterol Hepatol (2005) 1.00
Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One (2013) 1.00
The predicted impact of coding single nucleotide polymorphisms database. Cancer Epidemiol Biomarkers Prev (2005) 0.98
Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am J Clin Nutr (2009) 0.98
The epidemiology of delirium: challenges and opportunities for population studies. Am J Geriatr Psychiatry (2013) 0.96
Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis (2007) 0.96
Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis. PLoS One (2010) 0.95
Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens. PLoS One (2009) 0.94
Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. J Infect Dis (2002) 0.93
Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am J Public Health (2010) 0.92
Perthes' disease of the hip: socioeconomic inequalities and the urban environment. Arch Dis Child (2012) 0.92
Hepatitis B treatment in resource poor settings: time for action. Trop Med Int Health (2009) 0.92
Long-lived memory B-cell responses following BCG vaccination. PLoS One (2012) 0.92
Seasonal variation in respiratory syncytial virus epidemics in the Gambia, West Africa. Pediatr Infect Dis J (2004) 0.92
Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol (2007) 0.92
Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection. Environ Health Perspect (2011) 0.91
Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001. BMC Med (2004) 0.90
Public health trials in West Africa: logistics and ethics. IRB (1990) 0.89
Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. PLoS One (2013) 0.89
Mortality of hepatitis B surface antigen-positive blood donors in England and Wales. Int J Epidemiol (2003) 0.89
Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Virol J (2008) 0.88